Exhibit 99.1
Arbe Announces Q3 2024 Financial Results
TEL AVIV, Israel, Nov. 27, 2024 /PRNewswire/ -- Arbe Robotics Ltd. (Nasdaq: ARBE) (TASE: ARBE) (“Arbe”), a global leader in Perception Radar Solutions, today announced financial results for its third quarter, ended September 30, 2024.
Key Q3 and Recent Company Highlights:
● OEM Engagements:
- Arbe experienced significant growth in both the number and the depth of our OEM engagements. The company is in active process with 16 OEMs, 12 of which progressed to the bid stage, and 8 entered the advanced perception project phase.
- Arbe collaborated with a leading European truck manufacturer, which plans to incorporate Arbe’s radar chipset into its next-generation sensor suite.
● Collaborations with Tier-1s:
- HiRain Technologies accelerated the development of an ADAS system for a Chinese OEM, with the aim of replacing LiDAR with Arbe’s radar chipset.
- Sensrad signed a framework agreement to supply 4D imaging radars, powered by Arbe’s technology, to Tianyi Transportation Technology in China.
● Growing Market Demand: Arbe observed increasing interest in its radar technology from emerging verticals beyond automotive and is actively working with customers to address these opportunities.
● Successful Capital Raise: Arbe completed an offering of up to $49 million, of which $15 million were received upfront and up to $34 million will be received upon the exercise in full for cash of long-term and milestone-linked warrants. The public offering was led by existing investor AWM Investment Company Inc. and joined by new investors. The proceeds will support the planned production ramp-up in 2025. Canaccord Genuity served as the sole bookrunner, with Roth Capital Partners acting as co-manager.
“This quarter, we made significant progress in testing and deliveries for leading European OEMs,” said Kobi Marenko, Chief Executive Officer. “While the selection process has taken longer than anticipated, we remain on track toward achieving our design-in objectives. We are proud to have completed a public offering, welcoming both new and existing investors. This investment demonstrates their confidence in our progress and long-term vision.
In Q3, we achieved important milestones with our Tier-1s HiRain and Sensrad. With HiRain, we are enhancing global automotive safety by
providing radar capabilities traditionally associated with other sensor technologies. Sensrad’s recent agreement underscores the growing
demand for advanced innovative radar solutions across industries beyond automotive.”
Third Quarter 2024 Financial Highlights
Revenues for Q3 2024 were $0.1 million, a decrease from $0.5 million in Q3 2023. Backlog as of September 30, 2024, was $0.5 million.
Negative gross profit for Q3 2024 was $0.3 million, compared to a positive gross profit of $0.1 million / 24% in Q3 2023, mainly related to the reduction in revenue with a fixed cost level of expenses.
Operating expenses in Q3 2024 were $12.2 million, compared to $11.7 million in Q3 2023. The increase in operating expenses was primarily driven by an increased investment in outsourced support (both in headcount and overall expenses) as well as an increase in our internal workforce.
Net loss in the third quarter of 2024 increased to $12.6 million, compared to a net loss of $11.7 million in the third quarter of 2023. Net loss in Q3 2024 included $0.1 million of financial expenses, including bond revaluations partially offset by interest deposit gains.
Adjusted EBITDA, a non-GAAP measurement which excludes expenses for non-cash share-based compensation and for non-recurring items, for Q3 2024, yielded a loss of $8.2 million, compared to a loss of $7.5 million in the third quarter of 2023.
Balance Sheet & Liquidity
As of September 30, 2024, Arbe had $19.1 million in cash and cash equivalents.
2
Outlook
| ● | Our goal of achieving 4 design-ins with automakers remains unchanged, as we observe continued strong interest in our market-leading offering. |
| ● | We have strengthened our position in all our RFQ engagements, even though the OEMs have shifted their decision timelines from late 2023 to 2024. |
| ● | The 2024 annual revenues are expected to be in line with those of 2023, followed by revenue growth in 2025. These revenue projections are based on the intention to be in full production in the second half of 2024, as well as our decision to exclusively focus on getting our chipset into production. |
| ● | We are committed to maintaining a strong and well-managed balance sheet, focusing on cost-effectiveness and the ability to fund our revenue growth. Adjusted EBITDA for 2024 is projected to be in the range of ($30) million to ($36) million. |
Conference Call & Webcast Details
Arbe will host a conference call and webcast today at 8:30 am ET. Speakers will include Kobi Marenko, Chief Executive Officer, Co-Founder and Director, and Karine Pinto-Flomenboim, Chief Financial Officer. The Company encourages participants to pre-register for the conference call here. Callers will receive a unique dial-in upon registration, which enables immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.
The live call may be accessed via telephone at:
Toll Free: 1-(844) 481-3015
Israel Toll Free: 1-809-212373
Internationally: 1-(412) 317-1880
A telephonic replay of the conference call will be available until December 11, 2024, following the end of the conference call. To listen to the replay, please dial:
U.S. Toll Free: 1-877-344-7529
International: 1-412-317-0088
Access ID: 5174719
A live webcast of the call can be accessed here or from Arbe’s Investor Relations website at https://ir.arberobotics.com/news/ir-calendar. An archived webcast of the conference call will also be made available on the website following the call.
3
Arbe (Nasdaq, TASE: ARBE), a global leader in Perception Radar Solutions, is spearheading a radar revolution, enabling truly safe driver-assist systems today while paving the way to full autonomous-driving. Arbe’s radar technology is 100 times more detailed than any other radar on the market and is a critical sensor for L2+ and higher autonomy. The company is empowering automakers, Tier-1 suppliers, autonomous ground vehicles, commercial and industrial vehicles, and a wide array of safety applications with advanced sensing and paradigm changing perception. Arbe, a leader in the fast-growing automotive radar market, is based in Tel Aviv, Israel, and has offices in China, Germany, and the United States.
Cautionary Note Regarding Forward-Looking Statements
This press release contains, and the webcast will contain “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, both as amended by the Private Securities Litigation Reform Act of 1995. The words “expect,” “believe,” “estimate,” “intend,” “plan,” “anticipate,” “may,” “should,” “strategy,” “future,” “will,” “project,” “potential” and similar expressions indicate forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. These risks and uncertainties include, our ability to meet the milestones for the balance of our equity financing, the effect on the Israeli economy generally and on the Company’s business resulting from the terrorism and the hostilities in Israel and with its neighboring countries including the effects of the continuing war with Hamas and any further intensification of hostilities with others, including Iran and Hezbollah, and the effect of the call-up of a significant portion of its working population, including the Company’s employees; the effect of any potential boycott both of Israeli products and business and of stocks in Israeli companies; the effect of any downgrading of the Israeli economy and the effect of changes in the exchange rate between the US dollar and the Israeli shekel; and the risk and uncertainties described in “Cautionary Note Regarding Forward-Looking Statements,” “Item 3. Key Information – D. Risk Factors” and “Item 5. Operating and Financial Review and Prospects” and in the Company’s Annual Report on Form 20-F for the year ended December 31, 2023, which was filed with the Securities and Exchange Commission (the “SEC”) on March 28, 2024, as well as other documents filed by the Company with the SEC. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements relate only to the date they were made, and the Company does not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required by law or applicable regulation.
Information contained on, or that can be accessed through, the Company’s website or any other website or any social media is expressly not incorporated by reference into and is not a part of this press release.
4
CONSOLIDATED BALANCE SHEETS | ||||||||
| (U.S. dollars in thousands) | ||||||||
| Sep 30, 2024 | December 31, 2023 | |||||||
| Current Assets: | (Unaudited) | (Unaudited) | ||||||
| Cash and cash equivalents | 18,788 | 28,587 | ||||||
| Restricted cash | 280 | 163 | ||||||
| Short term bank deposits | 20 | 15,402 | ||||||
| Trade receivable | 618 | 1,258 | ||||||
| Other assets | 30,417 | - | ||||||
| Prepaid expenses and other receivables | 2,114 | 2,026 | ||||||
| Total current assets | 52,237 | 47,436 | ||||||
| Non-Current Assets | ||||||||
| Operating lease right-of-use assets | 1,800 | 1,740 | ||||||
| Property and equipment, net | 1,429 | 1,309 | ||||||
| Total non-current assets | 3,229 | 3,049 | ||||||
| Total assets | 55,466 | 50,485 | ||||||
| Current liabilities: | ||||||||
| Trade payables | 942 | 1,149 | ||||||
| Operating lease liabilities | 524 | 436 | ||||||
| Employees and payroll accruals | 3,096 | 2,916 | ||||||
| Convertible bonds | 30,836 | - | ||||||
| Accrued expenses and other payables | 871 | 1,710 | ||||||
| Total current liabilities | 36,269 | 6,211 | ||||||
| Long term liabilities | ||||||||
| Operating lease liabilities | 1,443 | 1,306 | ||||||
| Warrant liabilities | 540 | 875 | ||||||
| Total long-term liabilities | 1,983 | 2,181 | ||||||
| SHAREHOLDERS’ EQUITY: | ||||||||
| Ordinary Shares | * | ) | * | ) | ||||
| Additional paid-in capital | 257,976 | 245,733 | ||||||
| Accumulated Deficit | (240,762 | ) | (203,640 | ) | ||||
| Total shareholders’ equity | 17,214 | 42,093 | ||||||
| Total liabilities and shareholders’ equity | 55,466 | 50,485 | ||||||
| *) | Represents less than $1. |
5
CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||
| (U.S. dollars in thousands, except share and per share data) | ||||||||||||||||
| 3 Months Ended | 3 Months Ended | 9 Months Ended | 9 Months Ended | |||||||||||||
| Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2024 | Sep 30, 2023 | |||||||||||||
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||||
| Revenues | 123 | 479 | 669 | 1,123 | ||||||||||||
| Cost of revenues | 394 | 364 | 1,245 | 971 | ||||||||||||
| Gross profit (loss) | (271 | ) | 115 | (576 | ) | 152 | ||||||||||
| Operating Expenses: | ||||||||||||||||
| Research and development, net | 8,762 | 8,421 | 26,072 | 25,636 | ||||||||||||
| Sales and marketing | 1,426 | 1,264 | 4,243 | 3,666 | ||||||||||||
| General and administrative | 1,988 | 1,993 | 5,927 | 5,637 | ||||||||||||
| Total operating expenses | 12,176 | 11,678 | 36,242 | 34,939 | ||||||||||||
| Operating loss | (12,447 | ) | (11,563 | ) | (36,818 | ) | (34,787 | ) | ||||||||
| Financial expenses (income), net | 127 | 134 | 303 | (573 | ) | |||||||||||
| Net loss | (12,574 | ) | (11,697 | ) | (37,121 | ) | (34,215 | ) | ||||||||
| Basic net loss per ordinary share | (0.16 | ) | (0.15 | ) | (0.46 | ) | (0.49 | ) | ||||||||
| Weighted-average number of shares used in computing basic net loss per ordinary share | 80,957,931 | 77,474,326 | 79,914,649 | 69,975,104 | ||||||||||||
| Diluted net loss per ordinary share | (0.19 | ) | (0.18 | ) | (0.58 | ) | (0.56 | ) | ||||||||
| Weighted-average number of shares used in computing diluted net loss per ordinary share | 66,586,095 | 67,286,305 | 64,503,654 | 61,452,569 | ||||||||||||
6
CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||||||||||
| (U.S. dollars in thousands) | ||||||||||||||||
| 3 Months Ended | 3 Months Ended | 9 Months Ended | 9 Months Ended | |||||||||||||
| Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2024 | Sep 30, 2023 | |||||||||||||
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||||||
| Cash flows from operating activities: | ||||||||||||||||
| Net Loss | (12,574 | ) | (11,697 | ) | (37,121 | ) | (34,215 | ) | ||||||||
| Adjustments to reconcile loss to net cash used in operating activities: | ||||||||||||||||
| Depreciation | 148 | 139 | 437 | 415 | ||||||||||||
| Stock-based compensation | 3,800 | 3,707 | 11,399 | 9,428 | ||||||||||||
| Warrants to service providers | 291 | 178 | 639 | 432 | ||||||||||||
| Revaluation of warrants and accretion | (67 | ) | (252 | ) | (335 | ) | (490 | ) | ||||||||
| Revaluation of convertible bonds accretion | 117 | - | 140 | - | ||||||||||||
| Change in operating assets and liabilities: | ||||||||||||||||
| Decrease in trade receivable | 76 | 24 | 640 | 186 | ||||||||||||
| Decrease (increase) in prepaid expenses and other receivables | (160 | ) | 58 | (88 | ) | 562 | ||||||||||
| Decrease in other assets | 128 | - | - | - | ||||||||||||
| Issuance costs related to convertible bonds | 737 | - | 737 | - | ||||||||||||
| Operating lease ROU assets and liabilities, net | 31 | (5 | ) | 165 | (4 | ) | ||||||||||
| Increase (decrease) in trade payables | 85 | (368 | ) | (231 | ) | (652 | ) | |||||||||
| Increase (decrease) in employees and payroll accruals | (169 | ) | 210 | 180 | (340 | ) | ||||||||||
| Decrease in accrued expenses and other payables | (225 | ) | (83 | ) | (839 | ) | (3,789 | ) | ||||||||
| Net cash used in operating activities | (7,782 | ) | (8,089 | ) | (24,277 | ) | (28,467 | ) | ||||||||
| Cash flows from investing activities: | ||||||||||||||||
| Change in bank deposits | 17,663 | (13 | ) | 15,382 | (25,215 | ) | ||||||||||
| Purchase of property and equipment | (119 | ) | (71 | ) | (533 | ) | (190 | ) | ||||||||
| Net cash provided by (used in) investing activities | 17,544 | (84 | ) | 14,849 | (25,405 | ) | ||||||||||
| Cash flows from financing activities: | ||||||||||||||||
| Proceeds from issuance of ordinary shares, net of issuance costs | - | - | - | 22,496 | ||||||||||||
| Issuance costs related to convertible bonds | - | - | (459 | ) | - | |||||||||||
| Proceeds from exercise of options | 185 | 97 | 205 | 703 | ||||||||||||
| Net cash provided by (used in) financing activities | 185 | 97 | (254 | ) | 23,199 | |||||||||||
| Effect of exchange rate fluctuations on cash and cash equivalent | (17 | ) | (655 | ) | 197 | (721 | ) | |||||||||
| Increase (decrease) in cash, cash equivalents and restricted cash | 9,964 | (7,421 | ) | (9,879 | ) | (29,952 | ) | |||||||||
| Cash, cash equivalents and restricted cash at the beginning of period | 9,120 | 31,718 | 28,750 | 54,315 | ||||||||||||
| Cash, cash equivalents and restricted cash at the end of period | 19,068 | 23,642 | 19,068 | 23,642 | ||||||||||||
7
RECONCILIATION OF GAAP NET LOSS TO NON-GAAP NET LOSS | ||||||||||||||||
| (U.S. dollars in thousands, except share and per share data) | ||||||||||||||||
| 3 Months Ended | 3 Months Ended | 9 Months Ended | 9 Months Ended | |||||||||||||
| Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2024 | Sep 30, 2023 | |||||||||||||
| GAAP net loss attributable to ordinary shareholders | (12,574 | ) | (11,697 | ) | (37,121 | ) | (34,215 | ) | ||||||||
| Add: | ||||||||||||||||
| Stock-based compensation | 3,800 | 3,707 | 11,399 | 9,428 | ||||||||||||
| Warrants to service providers | 291 | 178 | 639 | 432 | ||||||||||||
| Revaluation of warrants and accretion | (67 | ) | (252 | ) | (335 | ) | (490 | ) | ||||||||
| Convertible bonds accretion | 117 | - | 140 | - | ||||||||||||
| Non-recurring expenses related to convertible bonds and ATM | - | - | 805 | 214 | ||||||||||||
| Non-GAAP net loss | (8,433 | ) | (8,064 | ) | (24,473 | ) | (24,631 | ) | ||||||||
| Basic Non-GAAP net loss per ordinary share | (0.10 | ) | (0.10 | ) | (0.31 | ) | (0.35 | ) | ||||||||
| Weighted-average number of shares used in computing basic Non-GAAP net loss per ordinary share | 80,957,931 | 77,474,326 | 79,914,649 | 69,975,104 | ||||||||||||
| Diluted Non-GAAP net loss per ordinary share | (0.13 | ) | (0.12 | ) | (0.38 | ) | (0.40 | ) | ||||||||
| Weighted-average number of shares used in computing diluted Non-GAAP net loss per ordinary share | 66,586,095 | 67,286,305 | 64,503,654 | 61,452,569 | ||||||||||||
8
| RECONCILIATION OF GAAP NET LOSS TO ADJUSTED EBITDA | ||||||||||||||||
| (U.S. dollars in thousands) | ||||||||||||||||
| 3 Months Ended | 3 Months Ended | 9 Months Ended | 9 Months Ended | |||||||||||||
| Sep 30, 2024 | Sep 30, 2024 | Sep 30, 2024 | Sep 30, 2024 | |||||||||||||
| GAAP net loss attributable to ordinary shareholders | (12,574 | ) | (11,697 | ) | (37,121 | ) | (34,215 | ) | ||||||||
| Add: | ||||||||||||||||
| Financial expenses (income), net | 127 | 134 | 303 | (573 | ) | |||||||||||
| Depreciation | 148 | 139 | 437 | 415 | ||||||||||||
| Stock-based compensation | 3,800 | 3,707 | 11,399 | 9,428 | ||||||||||||
| Warrants to service providers | 291 | 178 | 639 | 432 | ||||||||||||
| Non-recurring expenses related to ATM | - | - | 68 | 214 | ||||||||||||
| Adjusted EBITDA | (8,208 | ) | (7,539 | ) | (24,275 | ) | (24,299 | ) | ||||||||
CONTACT: Miri Segal-Scharia, msegal@ms-ir.com, 917-607-8654
9